Study finds Scipher RA test can predict nonresponders to TNF inhibitors July 29, 2020 By Stacy Lawrence Startup Scipher Medicine, of Waltham, Mass., is developing a blood test to predict which rheumatoid arthritis (RA) patients will not respond to Tumor necrosis factor (TNF) inhibitor therapies. Read More
